Nvidia executives struck a cautious note on the company’s China business during its quarterly earnings call Wednesday. CEO ...

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...

The electric vehicle giant’s stock hit a fresh 2025 low on Thursday, now down 25% year to date. Tesla shareholders haven’t ...

If bearishness takes over the market, expect CRM to be part of a deep sell-off that pushes the stock back to the ...

Shares of Snowflake Inc. climbed after the company forecast higher-than-expected product revenue growth for the current fiscal year as it boosts its artificial-intelligence offering. The stock was up ...

Some of the $500 billion that Apple pledged Monday to invest in the U.S. will go to the massive Taiwan Semiconductor ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on C3ai (AI – Research Report), with a price target of $45.00. The ...

Wedbush analyst Daniel Ives maintained a Buy rating on Pegasystems (PEGA – Research Report) today and set a price target of $125.00. The ...

Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico ...

Dan Ives, Global Head of Technology Research at Wedbush Securities, talks about how Deepseek has transformed China's role in ...

Nvidia has also expanded the products it sells beyond semiconductors, reducing opportunities for companies like Dell or HPE ...

NVDA stock rose after hours as Nvidia's earnings results beat estimates. Blackwell chips brought in $11 billion for Nvidia, ...